Susan Yehle Ritter, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Synovial Fluid | 4 | 2016 | 393 | 0.510 |
Why?
|
Osteoarthritis, Knee | 3 | 2016 | 1234 | 0.500 |
Why?
|
Proteome | 2 | 2014 | 1862 | 0.440 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2192 | 0.350 |
Why?
|
Cartilage | 2 | 2013 | 806 | 0.340 |
Why?
|
Synovial Membrane | 1 | 2013 | 532 | 0.340 |
Why?
|
Methotrexate | 2 | 2020 | 1719 | 0.190 |
Why?
|
Proteomics | 2 | 2014 | 3848 | 0.190 |
Why?
|
Antirheumatic Agents | 2 | 2020 | 1372 | 0.160 |
Why?
|
RNA, Messenger | 1 | 2013 | 12794 | 0.150 |
Why?
|
Keratan Sulfate | 1 | 2014 | 17 | 0.120 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 649 | 0.120 |
Why?
|
Osteoarthritis | 2 | 2013 | 1063 | 0.120 |
Why?
|
Angioedema | 1 | 2016 | 184 | 0.120 |
Why?
|
Chondrocytes | 3 | 2016 | 795 | 0.120 |
Why?
|
Clusterin | 1 | 2014 | 71 | 0.120 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2014 | 141 | 0.120 |
Why?
|
Arthritis, Experimental | 1 | 2016 | 291 | 0.110 |
Why?
|
Acute-Phase Reaction | 1 | 2013 | 91 | 0.110 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 283 | 0.110 |
Why?
|
Dermatomyositis | 1 | 2016 | 258 | 0.110 |
Why?
|
Acute-Phase Proteins | 1 | 2013 | 250 | 0.100 |
Why?
|
Complement Membrane Attack Complex | 1 | 2011 | 105 | 0.100 |
Why?
|
Complement C5 | 1 | 2011 | 103 | 0.100 |
Why?
|
NFATC Transcription Factors | 1 | 2013 | 389 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1069 | 0.100 |
Why?
|
Blood Coagulation Factors | 1 | 2013 | 365 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2013 | 735 | 0.090 |
Why?
|
Glycoproteins | 1 | 2014 | 2203 | 0.070 |
Why?
|
Cartilage, Articular | 1 | 2013 | 1099 | 0.070 |
Why?
|
Linear Models | 1 | 2014 | 5872 | 0.060 |
Why?
|
Knee Joint | 1 | 2013 | 1676 | 0.060 |
Why?
|
Radiography | 1 | 2014 | 6965 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13446 | 0.050 |
Why?
|
Peptides | 1 | 2014 | 4358 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4948 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2013 | 9420 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 616 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11904 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13510 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15501 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1667 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22176 | 0.030 |
Why?
|
Chondrogenesis | 1 | 2016 | 239 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2016 | 14416 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12341 | 0.030 |
Why?
|
Hematinics | 1 | 2017 | 282 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 29629 | 0.030 |
Why?
|
Middle Aged | 4 | 2020 | 220920 | 0.030 |
Why?
|
Aged | 3 | 2020 | 169310 | 0.030 |
Why?
|
Bone Development | 1 | 2016 | 472 | 0.030 |
Why?
|
Thyrotropin | 1 | 2016 | 834 | 0.030 |
Why?
|
Complement C6 | 1 | 2011 | 14 | 0.020 |
Why?
|
Edema | 1 | 2016 | 766 | 0.020 |
Why?
|
Cohort Studies | 1 | 2014 | 41493 | 0.020 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2011 | 102 | 0.020 |
Why?
|
Neck | 1 | 2016 | 734 | 0.020 |
Why?
|
Male | 5 | 2020 | 360842 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 456 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2016 | 625 | 0.020 |
Why?
|
Folic Acid | 1 | 2017 | 1323 | 0.020 |
Why?
|
Joints | 1 | 2011 | 322 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 615 | 0.020 |
Why?
|
Humans | 8 | 2022 | 761572 | 0.020 |
Why?
|
Female | 4 | 2020 | 392686 | 0.020 |
Why?
|
Gene Deletion | 1 | 2016 | 2665 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4124 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2016 | 2161 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 2639 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6766 | 0.010 |
Why?
|
Mice | 3 | 2016 | 81533 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7396 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6180 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12975 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18965 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11076 | 0.010 |
Why?
|
Animals | 3 | 2016 | 168467 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9469 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15936 | 0.010 |
Why?
|
Hypertension | 1 | 2016 | 8540 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54426 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18253 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74213 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36429 | 0.000 |
Why?
|